NCT01486979View on ClinicalTrials.gov

Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic Vaginitis

PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
MenopausePostmenopausal Vaginal Atrophy
Interventions
DRUG

estradiol, 10 mcg

One vaginal tablet once daily in the morning during the first two weeks of treatment followed by one vaginal tablet twice weekly in the morning for 10 weeks

DRUG

estradiol, 25 mcg

One vaginal tablet once daily in the morning during the first two weeks of treatment followed by one vaginal tablet twice weekly in the morning for 10 weeks

Trial Locations (1)

89231

Novo Nordisk Investigational Site, Neu-Ulm

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT01486979 - Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic Vaginitis | Biotech Hunter | Biotech Hunter